search
Back to results

Social Support Intervention Targeting Patients Treated for Cardiac Disease Who Experience Loneliness

Primary Purpose

Feasibility

Status
Recruiting
Phase
Not Applicable
Locations
Denmark
Study Type
Interventional
Intervention
Social support
Sponsored by
Rigshospitalet, Denmark
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for Feasibility focused on measuring Loneliness, Social support, cardiac

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • Patients treated for Ischemic heart disease (CABG or PCI), valve disease (TAVR, SAVR), and arrhythmia (ICD, pacemaker implantation or ablation) treated at Rigshospitalet and classified as high risk lonely according to the High Risk Loneliness (HiRL) tool

Exclusion Criteria:

  • Patients who are unable to provide written consent, therefore, patients with severe cognitive or physical dysfunction will not be approached

Sites / Locations

  • Rigshospitalet, Copenhagen University HospitalRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

No Intervention

Arm Label

Intervention

Control

Arm Description

Six month social support intervention following in hospital cardiac treatment

Regular follow-up

Outcomes

Primary Outcome Measures

Feasibility, Acceptability
Percentage of eligible patients who agree to participate in the trial
Feasibility, Adherence
Percentage of patients in contact with the informal caregiver at least once a week face to face, by phone or virtually.

Secondary Outcome Measures

Measure of social network members as informal caregivers
Percentage of potential caregivers who accepts to be an informal caregiver
Measure of informal caregivers
Percentage of informal caregivers participating in all three intervention consultations with the trial staff
Resource consumption
Time resources used to complete the three nurse consultations

Full Information

First Posted
August 10, 2022
Last Updated
March 28, 2023
Sponsor
Rigshospitalet, Denmark
search

1. Study Identification

Unique Protocol Identification Number
NCT05503810
Brief Title
Social Support Intervention Targeting Patients Treated for Cardiac Disease Who Experience Loneliness
Official Title
Feasibility Randomized Trial of a Social Support Intervention Plus Usual Care Versus Usual Care, Targeting Patients Treated for Cardiac Disease Who Experience Loneliness
Study Type
Interventional

2. Study Status

Record Verification Date
August 2022
Overall Recruitment Status
Recruiting
Study Start Date
October 5, 2022 (Actual)
Primary Completion Date
January 2024 (Anticipated)
Study Completion Date
January 2025 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Rigshospitalet, Denmark

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Introduction: In patients treated for cardiac disease, loneliness is known to contribute negatively to health behavior, health outcome and increase risk of cardiac and all-cause mortality. Even so, in health care research, social support interventional studies targeting patients who experience loneliness is lacking. Aim: To determine the feasibility of an individually structured social support intervention targeting patients treated for cardiac disease who experience loneliness. Design: A feasibility study based on randomized clinical trial design with 1:1 randomization to a 6-month social support program, plus usual care (intervention) versus usual care, (i.e., regular guidelines-based follow-up). Intervention: Patients classified as high risk lonely according to the High Risk Loneliness tool will be provided with an informal caregiver in the six months rehabilitation phase following cardiac disease treatment. The informal caregiver will be designated by the patient from the existing social network or a peer, depending on patients' preferences. The core content of the intervention is through nurse consultations at baseline, one, three and six months, to enhance and reinforce the informal caregiver's competences to be a social support resource. The theoretical framework of the nurse consolations will be based on Middle-range theory of self-care. Outcome: Feasibility will be evaluated in terms of acceptability and adherence according to predefined feasibility criteria. The preliminary effect of the intervention on patient-reported outcomes, health behaviors and health outcomes will be evaluated in the intervention and the control group at baseline, one, three, six and twelve months.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Feasibility
Keywords
Loneliness, Social support, cardiac

7. Study Design

Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Randomized clinical trial design with 1:1 randomization
Masking
None (Open Label)
Allocation
Randomized
Enrollment
40 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Intervention
Arm Type
Experimental
Arm Description
Six month social support intervention following in hospital cardiac treatment
Arm Title
Control
Arm Type
No Intervention
Arm Description
Regular follow-up
Intervention Type
Behavioral
Intervention Name(s)
Social support
Other Intervention Name(s)
Loneliness reduction
Intervention Description
Contact ones a week with Informal caregiver or peer support
Primary Outcome Measure Information:
Title
Feasibility, Acceptability
Description
Percentage of eligible patients who agree to participate in the trial
Time Frame
Measured at baseline
Title
Feasibility, Adherence
Description
Percentage of patients in contact with the informal caregiver at least once a week face to face, by phone or virtually.
Time Frame
6 months follow-up after in-hospital cardiac treatment
Secondary Outcome Measure Information:
Title
Measure of social network members as informal caregivers
Description
Percentage of potential caregivers who accepts to be an informal caregiver
Time Frame
Measured at baseline
Title
Measure of informal caregivers
Description
Percentage of informal caregivers participating in all three intervention consultations with the trial staff
Time Frame
3 months follow-up after in-hospital cardiac treatment
Title
Resource consumption
Description
Time resources used to complete the three nurse consultations
Time Frame
6 months follow-up after in-hospital cardiac treatment
Other Pre-specified Outcome Measures:
Title
Loneliness
Description
High Risk Loneliness tool. 2 item. Screeningscore 0 to 2, with a higher score indicating worse outcome
Time Frame
Baseline, one, three, six and twelve months
Title
Self-care
Description
Self Care Self-Efficacy scale. 10 item scale answered on a Likert scale 1 to 5 with a lower score indicating worse outcome
Time Frame
Baseline, one, three, six and twelve months
Title
Health-related quality of life
Description
HeartQoL. 10 item scale answered on a Likert scale 0-5, with a higher score indicating worse outcome
Time Frame
Baseline, one, three, six and twelve months
Title
Anxiety and Depression
Description
Hospital Anxiety and Depression scale (HADS). 14 item scale. The scale offers two scores, HADS-A (anxiety) and HADS-D (depression). Answered in a Likert scale with a higher score indicating worse outcome
Time Frame
Baseline, one, three, six and twelve months
Title
Health behaviors
Description
Smoking, alcohol consumption, weight, physical activity, participation in cardiac rehabilitation
Time Frame
Baseline, one, three, six and twelve months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Patients treated for Ischemic heart disease (CABG or PCI), valve disease (TAVR, SAVR), and arrhythmia (ICD, pacemaker implantation or ablation) treated at Rigshospitalet and classified as high risk lonely according to the High Risk Loneliness (HiRL) tool Exclusion Criteria: Patients who are unable to provide written consent, therefore, patients with severe cognitive or physical dysfunction will not be approached
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Mitti Blakø, PhD
Phone
+45 20915919
Email
mitti.blakoe@regionh.dk
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Selina K Berg, Professor
Organizational Affiliation
Rigshospitalet, Denmark
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Mitti Blakø, PhD
Organizational Affiliation
Rigshospitalet, Denmark
Official's Role
Study Director
First Name & Middle Initial & Last Name & Degree
Anne V Christensen, PhD
Organizational Affiliation
Rigshospitalet, Denmark
Official's Role
Study Chair
First Name & Middle Initial & Last Name & Degree
Pernille Palm, PhD
Organizational Affiliation
Rigshospitalet, Denmark
Official's Role
Study Chair
First Name & Middle Initial & Last Name & Degree
Ida E Hojskov, PhD
Organizational Affiliation
Rigshospitalet, Denmark
Official's Role
Study Chair
First Name & Middle Initial & Last Name & Degree
Camilla Bernild, PhD
Organizational Affiliation
Rigshospitalet, Denmark
Official's Role
Study Chair
Facility Information:
Facility Name
Rigshospitalet, Copenhagen University Hospital
City
Copenhagen
ZIP/Postal Code
2100
Country
Denmark
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Selina K Berg, PhD
Phone
+4535459526
Email
selina@rh.dk
First Name & Middle Initial & Last Name & Degree
Anne V Christensen, PhD
Phone
+4530182684
Email
anne.vinggaard.christensen@regionh.dk

12. IPD Sharing Statement

Learn more about this trial

Social Support Intervention Targeting Patients Treated for Cardiac Disease Who Experience Loneliness

We'll reach out to this number within 24 hrs